Published in
Elsevier, American Heart Journal, (178), p. 55-64, 2016
DOI: 10.1016/j.ahj.2016.03.017
Links
Tools
Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
Journal article published in 2016 by
Padma Kaul 
,
E. Magnus Ohman,
J. David Knight,
Kevin J. Anstrom,
Matthew T. Roe,
William E. Boden,
Judith S. Hochman,
Vladimir Gašparović,
Paul W. Armstrong,
Patrick McCollam,
Walid Fakhouri,
Patricia Cowper,
Linda Davidson-Ray,
Nancy Clapp-Channing,
Harvey D. White
and other authors.
,
E. Magnus Ohman,
J. David Knight,
Kevin J. Anstrom,
Matthew T. Roe,
William E. Boden,
Judith S. Hochman,
Vladimir Gašparović,
Paul W. Armstrong,
Patrick McCollam,
Walid Fakhouri,
Patricia Cowper,
Linda Davidson-Ray,
Nancy Clapp-Channing,
Harvey D. White
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 